AU2002241661A1 - Multifunctional protease inhibitors and their use in treatment of disease - Google Patents

Multifunctional protease inhibitors and their use in treatment of disease

Info

Publication number
AU2002241661A1
AU2002241661A1 AU2002241661A AU2002241661A AU2002241661A1 AU 2002241661 A1 AU2002241661 A1 AU 2002241661A1 AU 2002241661 A AU2002241661 A AU 2002241661A AU 2002241661 A AU2002241661 A AU 2002241661A AU 2002241661 A1 AU2002241661 A1 AU 2002241661A1
Authority
AU
Australia
Prior art keywords
disease
treatment
protease inhibitors
multifunctional protease
multifunctional
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU2002241661A
Other versions
AU2002241661B2 (en
Inventor
Philip J. Barr
Helen L. Gibson
Philip Pemberton
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Arriva Pharmaceuticals Inc
Original Assignee
Arriva Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arriva Pharmaceuticals Inc filed Critical Arriva Pharmaceuticals Inc
Priority claimed from PCT/US2001/049256 external-priority patent/WO2002050287A2/en
Publication of AU2002241661A1 publication Critical patent/AU2002241661A1/en
Application granted granted Critical
Publication of AU2002241661B2 publication Critical patent/AU2002241661B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

AU2002241661A 2000-12-18 2001-12-18 Multifunctional protease inhibitors and their use in treatment of disease Ceased AU2002241661B2 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US25669900P 2000-12-18 2000-12-18
US60/256,699 2000-12-18
US33196601P 2001-11-20 2001-11-20
US60/331,966 2001-11-20
PCT/US2001/049256 WO2002050287A2 (en) 2000-12-18 2001-12-18 Multifunctional protease inhibitors and their use in treatment of disease

Publications (2)

Publication Number Publication Date
AU2002241661A1 true AU2002241661A1 (en) 2002-09-05
AU2002241661B2 AU2002241661B2 (en) 2007-05-31

Family

ID=26945535

Family Applications (2)

Application Number Title Priority Date Filing Date
AU4166102A Pending AU4166102A (en) 2000-12-18 2001-12-18 Multifunctional protease inhibitors and their use in treatment of disease
AU2002241661A Ceased AU2002241661B2 (en) 2000-12-18 2001-12-18 Multifunctional protease inhibitors and their use in treatment of disease

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AU4166102A Pending AU4166102A (en) 2000-12-18 2001-12-18 Multifunctional protease inhibitors and their use in treatment of disease

Country Status (7)

Country Link
EP (1) EP1366175B1 (en)
JP (2) JP4426179B2 (en)
AT (1) ATE384800T1 (en)
AU (2) AU4166102A (en)
CA (1) CA2430973A1 (en)
DE (1) DE60132632T2 (en)
WO (1) WO2002050287A2 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1567183A4 (en) * 2002-12-06 2006-08-09 Arriva Pharmaceuticals Inc Methods and compositions for treatment of otitis media
EP1613653A1 (en) * 2003-04-08 2006-01-11 Genova Ltd. Secreted polypeptide species associated with cardiovascular disorders
EP2287326A1 (en) 2003-08-08 2011-02-23 Arriva Pharmaceuticals, Inc. Methods of protein production in yeast
SE0302559D0 (en) * 2003-09-25 2003-09-25 Astrazeneca Ab Method
EP1737499A4 (en) 2004-03-09 2009-07-22 Arriva Pharmaceuticals Inc Treatment of chronic obstructive pulmonary disease by low dose inhalation of protease inhibitor
JP2007037434A (en) * 2005-08-02 2007-02-15 Yamaguchi Univ ARTIFICIAL PROTEIN EXPRESSED PANCREATIC beta-CELL-SPECIFICALLY, REPORTER GENE ENCODING THE PROTEIN AND METHOD FOR MEASURING AMOUNT OF PANCREATIC betaCELL
JP2009532369A (en) * 2006-03-30 2009-09-10 リサーチ ファウンデーション オブ シティ ユニバーシティ オブ ニューヨーク Stimulation of nerve regeneration by secretory leukocyte protease inhibitor
WO2010041617A1 (en) * 2008-10-09 2010-04-15 公立大学法人横浜市立大学 Fusion protein composed of matrix metalloproteinase-2 inhibitor peptide derived from amyloid-β precursor protein and tissue inhibitor of metalloproteinase-2
JP5757639B2 (en) * 2010-09-14 2015-07-29 エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ Serpin finger fusion polypeptide
US10400029B2 (en) 2011-06-28 2019-09-03 Inhibrx, Lp Serpin fusion polypeptides and methods of use thereof
MX356517B (en) * 2011-06-28 2018-06-01 Inhibrx Llc Serpin fusion polypeptides and methods of use thereof.
AU2012337241B2 (en) 2011-12-30 2016-10-13 Grifols, S.A. Alpha1-proteinase inhibitor for delaying the onset or progression of pulmonary exacerbations
JP6436401B2 (en) * 2013-04-30 2018-12-12 ザ トラスティーズ オブ コロンビア ユニバーシティ イン ザ シティ オブ ニューヨーク Analysis of elastic fiber damage markers
WO2015039189A1 (en) 2013-09-18 2015-03-26 James Cook University Modified anti-inflammatory proteins and method of use
JP2016536343A (en) * 2013-09-18 2016-11-24 ジェームス・クック・ユニバーシティー Anti-inflammatory proteins and methods of use

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5900400A (en) * 1984-12-06 1999-05-04 Amgen Inc. Serine protease inhibitor analogs
DE3709255A1 (en) * 1987-03-20 1988-09-29 Hoechst Ag HYBRID SERPINS AND DAFUER-ENCODING DNA
US5633227A (en) * 1994-09-12 1997-05-27 Miles, Inc. Secretory leukocyte protease inhibitor as an inhibitor of tryptase
CA2289117A1 (en) * 1997-05-12 1998-11-19 Nederlandse Organisatie Voor Toegepast-Natuurwetenschappelijk Onderzoek Tno Method and construct for inhibition of cell migration
EP1231936A2 (en) * 1999-10-27 2002-08-21 K-Quay Enterprises, LLC Methods and compositions for treatment of keratoconus using protease inhibitors

Similar Documents

Publication Publication Date Title
AU2001259758A1 (en) Interleukin-1 inhibitors in the treatment of diseases
AU2001249918A1 (en) Inhibitors of inflammation and reperfusion injury and methods of use thereof
AU1166502A (en) Human ect2 and methods of use
HUP0301121A3 (en) Topical pharmaceutical formulations and methods of treatment
AU2001265008A1 (en) Caspase inhibitors and uses thereof
AU2001293553A1 (en) Phosphatidylserine-carrying apoptosis-mimicking bodies and the use thereof in medical treatment
AU2002225954A1 (en) Dipeptidylpeptidases and methods of use
AU2002241661A1 (en) Multifunctional protease inhibitors and their use in treatment of disease
AU2001283285A1 (en) Antimicrobial composition and methods of use in the treatment of disease
AU2002345255A1 (en) Composition comprising soy and use thereof in the prevention and/or treatment of various diseases
AU2002237667A1 (en) Methods for the treatment and prevention of urinary stone disease
AU2002213346A1 (en) Osteopontin-coated surfaces and methods of use
AU1334602A (en) Osteopontin-coated surfaces and methods of use
AU2001258381A1 (en) Use of parp inhibitors in cosmetic preparations
AU2002337913A1 (en) Glycosulfopeptide inhibitors and methods of use thereof
AU2002346594A1 (en) Use of hiv-1 protease inhibitors and their derivatives in the treatment of inflammation
AU2001257272A1 (en) Use of mmp inhibitors in filtering blebs and ischemia
AU2002220257A1 (en) Methods of treatment involving human mda-7
AU2003206945A1 (en) Use of proteinase inhibitors in the treatment of autoimmune diseases
AU2002223313A1 (en) Protease inhibitors and their pharmaceutical uses
AU2002363938A8 (en) Methods and use of motoneuronotropic factors
AU2001234962A1 (en) Mixtures of caspase inhibitors and complement inhibitors and methods of use thereof
AU2001261375A1 (en) Human caspase-12 materials and methods
AU2001242502A1 (en) Use of protease inhibitors in cosmetics and pharmacy
AU2001245414A1 (en) Treatment of allergies